SK
Satyam Krishna Dutta Dwivedi
About Satyam Krishna Dutta Dwivedi
Data last updated:
Satyam Krishna Dutta Dwivedi has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Feelcure Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Feelcure Pharmaceuticals Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 04 Oct 2024 | 2019 | ₹1.38 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyam Krishna Dutta Dwivedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyam Krishna Dutta Dwivedi
Satyam Krishna Dutta Dwivedi has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Feelcure Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Feelcure Pharmaceuticals Private Limited at ₹1.38 Cr (FY 2025).
Satyam Krishna Dutta Dwivedi is associated with 1 company as Additional Director, including Feelcure Pharmaceuticals Private Limited (₹1.38 Cr).
Satyam Krishna Dutta Dwivedi has expertise in General Business.
Satyam Krishna Dutta Dwivedi has 2 years in corporate governance.
By reported revenue, the largest current company of Satyam Krishna Dutta Dwivedi is Feelcure Pharmaceuticals Private Limited, with revenue of ₹1.38 Cr (FY 2025).
Satyam Krishna Dutta Dwivedi currently holds positions at 1 company: Feelcure Pharmaceuticals Private Limited (₹1.38 Cr).